No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis by Kienhöfer, D. et al.
RESEARCH ARTICLE
No Evidence of Pathogenic Involvement of
Cathelicidins in Patient Cohorts and Mouse
Models of Lupus and Arthritis
D. Kienho¨fer1, J. Hahn1, I. Schubert1, C. Reinwald1, N. Ipseiz1, S. C. Lang1,
E`. Bosch Borra`s2, K. Amann3, C. Sjo¨wall4, A. E. Barron5, A. J. Hueber1,
B. Agerberth6, G. Schett1, M. H. Hoffmann1*
1. Department of Internal Medicine 3, Universita¨tsklinikum Erlangen, Erlangen, Germany, 2. Universitat
Auto`noma de Barcelona, Barcelona, Spain, 3. Department of Nephropathology, Universita¨tsklinikum
Erlangen, Erlangen, Germany, 4. Rheumatology/AIR, Department of Clinical and Experimental medicine,
Linko¨ping university, Linko¨ping, Sweden, 5. Department of Bioengineering, Stanford University, Stanford, CA,
United States of America, 6. Division of Clinical Microbiology, F68, Department of Laboratory Medicine,
Karolinska University, Huddinge, Stockholm, Sweden
*markus.hoffmann@uk-erlangen.de
Abstract
Apart from their role in the immune defence against pathogens evidence of a role of
antimicrobial peptides (AMPs) in autoimmune diseases has accumulated in the
past years. The aim of this project was to examine the functional impact of the
human cathelicidin LL-37 and the mouse cathelicidin-related AMP (CRAMP) on the
pathogenesis of lupus and arthritis. Serum LL-37 and anti-LL-37 levels were
measured by ELISA in healthy donors and patients with Systemic Lupus
Erythematosus (SLE) and Rheumatoid arthritis (RA). Pristane-induced lupus was
induced in female wild type (WT) and cathelicidin-deficient (CRAMP2/2) mice.
Serum levels of anti-Sm/RNP, anti-dsDNA, and anti-histone were determined via
ELISA, cytokines in sera and peritoneal lavages were measured via Multiplex.
Expression of Interferon I stimulated genes (ISG) was determined by real-time
PCR. Collagen-induced arthritis (CIA) was induced in male WT and CRAMP2/2
mice and arthritis severity was visually scored and analysed histomorphometrically
by OsteoMeasure software. Serum levels of anti-LL-37 were higher in SLE-patients
compared to healthy donors or patients with RA. However, no correlation to
markers of disease activity or organ involvement was observed. No significant
differences of autoantibody or cytokine/chemokine levels, or of expression of ISGs
were observed between WT and CRAMP2/2 mice after pristane-injection.
Furthermore, lung and kidney pathology did not differ in the absence of CRAMP.
Incidence and severity of CIA and histological parameters (inflammation, cartilage
degradation, and bone erosion) were not different in WT and CRAMP2/2 mice.
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Although cathelicidins are upregulated in mouse models of lupus and arthritis,
cathelicidin-deficiency did not persistently affect the diseases. Also in patients with
SLE, autoantibodies against cathelicidins did not correlate with disease
manifestation. Reactivity against cathelicidins in lupus and arthritis could thus be an
epiphenomenon caused by extensive overexpression in blood and affected tissues.
In addition, other cationic AMPs could functionally compensate for the deficiency of
cathelicidins.
Introduction
Apart from their role in anti-microbial defence, anti-microbial peptides (AMPs)
such as the human cathelicidin LL-37 possess potent immunomodulatory
properties and have recently also been implicated in the pathogenesis of
autoimmune diseases [1–4]. In sera of patients with Systemic Lupus
Erythematosus (SLE), immune complexes of AMPs and self-DNA derived from
neutrophil extracellular traps (NETs) were reported to trigger activation of Toll-
like receptor (TLR) 9. Furthermore, SLE-patients were found to develop
autoantibodies (autoAbs) to both self-DNA and AMPs [2, 3].
Patients with SLE [5, 6] and a subset of RA patients [7] display a type I
interferon (IFN) signature in their peripheral blood mononuclear cells. Given
their reported role in SLE, AMPs may also stimulate TLR-pathways in other
autoimmune diseases characterized by reactivity to nucleic acids, such as arthritis.
In a previous study, we observed overexpression of LL-37 and its rat homologue
rCRAMP in arthritic joints of patients with RA and of rats, respectively. In rat
pristane-induced arthritis, the increased expression of rCRAMP coincided with
the development of anti-rCRAMP autoAbs [8].
We have now continued to further investigate the functional importance of
cathelicidins, using sera from patient cohorts with SLE and RA and cathelicidin-
deficient mice. Although we detected autoAbs to cathelicidins in humans and in
mice with lupus, they were not linked to disease activity or severity. Furthermore,
in mouse models of arthritis and inducible lupus, cathelicidin-deficient mice
developed a disease comparable in severity to wild type (WT) animals. Our results
therefore do not support previous reports about an indispensable role of
cathelicidins in the pathogenesis of lupus and arthritis.
Methods
Animals
C57BL/6 mice deficient of CRAMP (CRAMP2/2 mice) were created as described
[9] and kindly provided together with WT littermates by the groups of Lennart
Lindbom, Karolinska Institute, Sweden, and Oliver So¨hnlein, Technical University
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of Munich, Germany. Mice were bred and maintained at the animal facility of the
University of Erlangen-Nuremberg. Experiments were performed on mice
frequency-matched for age and sex, and evaluated with blinded identity.
Patients
In this study, 185 patients with SLE (mean age 44 years, range 18–77), 92 patients
with RA (mean age 49 years, range 20–107), and 67 sex-matched healthy controls
(mean age 39 years, range 25–72) from cohorts of the university hospitals
Erlangen and Linko¨ping (longitudinal samples with clinical data for SLE) were
included (S1 Table). All patients fulfilled at least 4 of the classification criteria for
SLE [10] and RA [11], respectively, and gave written informed consent. Disease
activity of the SLE patients was registered according to the SLE disease activity
index 2000 (SLEDAI). In the longitudinal follow up examination, patients with
more than 4 visits (follow up for .1 year) were considered for blood analysis and
recording of disease activity parameters (SLEDAI). All experiments were approved
by the local ethical committees (‘‘Linko¨ping university Ethical Review Board’’,
permit number M75-08, ‘‘Ethics committee of the university Erlangen’’, permit
number Re.-No. 3982 and Re.-No. 187_12B).
Experimental lupus and arthritis
Pristane-induced lupus (PIL) was induced by a single intraperitoneal (i.p.)
injection of 500 ml pristane (2, 6, 10, 14-tetramethyl-pentadecane; Sigma-Aldrich)
in female C57BL/6 CRAMP2/2 and corresponding WT mice with an age of 8–12
weeks and followed over a period of 6 months. A limited number of mice were
sacrificed after 14 days to enable histopathological analysis of the lungs and
cytokine measurement of peritoneal lavages.
Collagen-induced arthritis (CIA) was induced in 8–12 weeks old male C57BL/6
CRAMP2/2 and WT mice by intradermal (i.d.) injection of 100 mg chicken
collagen type II (Sigma-Aldrich) emulsified in 100 ml Incomplete Freund’s
Adjuvant (IFA) supplemented with 5 mg/ml Mycobacterium tuberculosis (both
from Sigma-Aldrich) at the base of the tail, followed by an i.d. booster injection of
100 mg CII/100 ml IFA 21 days later.
The severity of arthritis was graded visually by assessing the level of swelling in
each paw, including the tarsus or carpus joints. The following scoring system was
used: 0, no erythema/swelling; 1, erythema and swelling in up to two joints; 2,
erythema and swelling in more than two joints or slight swelling of the ankle; 3,
marked swelling of the ankle; 4, substantial swelling of the whole paw including
toes/fingers. The maximum score per mouse was 16.
All experiments were approved by the local ethical committee (‘‘Regierung von
Mittelfranken’’, permit number 54.2532.1-32/12).
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Analysis of organ involvement
To evaluate kidney involvement in PIL, proteinuria was determined with
semiquantitative urine testing strips (Albustix, Bayer) using midstream urine. For
assessing glomerular immune and complement deposits, mice were sacrificed and
perfused with PBS to minimize background. One kidney/mouse was embedded in
OCT Tissue-Tek compound (Sakura, Alphen aan den Rijn), snap-frozen, and
stored at 280 C˚ until use. 5 mm cryo-sections were fixed with acetone and stained
with FITC-labelled antibodies to murine complement factor C3 (Cedarlane) and
IgG (BioLegend), respectively. Glomerular deposits were scored by two blinded
individual scorers by immunofluorescence microscopy on a Nikon Eclipse 80i
microscope, utilizing a semiquantitative scoring system as described [12]. The
other kidney was fixated in Roti-Histofix (Carl Roth) and embedded in paraffin. A
Periodic acid Schiff (PAS) staining was prepared of 5 mm-sections, which were
analyzed with a Zeiss AxioLab.A1 microscope.
Analysis of CRAMP expression
Pristane was injected i.p. in WT and CRAMP2/2 mice and cells were collected via
peritoneal lavage with PBS or after erythrocyte lysis from peripheral blood at day 0
and 7 after injection. Cells were stained extracellularly with anti-CD11b-eFluor450
(eBioscience), anti-Ly6C-APC (BioLegend), anti-CD115-PE (BioLegend), and
anti-Ly6G-APC (BioLegend) to determine cell types. Intracellular CRAMP
staining was performed with an anti-CRAMP (Innovagen) antibody labelled with
an Alexa Fluor 488 antibody labelling kit (LifeTechnologies). Cells were then
analyzed by cytofluorometry on a Gallios machine (Beckman Coulter).
Determination of Autoantibodies and Serum Cytokine Levels
For detection of murine autoAbs by ELISA, microtiter plates were coated
overnight with 50 mg/ml histone from calf thymus (Roche Diagnostics), 1 mg/ml
Sm/RNP (GenWay Biotech), or precoated with 20 mg/ml poly-L-Lysine (Sigma-
Aldrich) before adding 20 mg/ml calf thymus DNA (Sigma-Aldrich), respectively.
PIL-sera were added at a 1:100 dilution in PBS/2% FCS. Bound IgG was detected
with 0.125 mg/ml horseradish peroxidase-conjugated goat anti-mouse IgG
(Southern Biotech) and substrate solution (eBioScience).
For detection of anti-LL-37, microtiter plates were coated with 1 mg/ml LL-37
(Innovagen) for 2 hours at room temperature. Sera were diluted 1:500 and
incubated for 90 min at room temperature. After several washing steps with PBS/
0.05% Tween, bound anti-LL-37 was detected using 0.02 mg/ml horseradish
peroxidase-conjugated goat anti-human IgG antibody (Southern Biotech) and
substrate solution (eBioScience). Detection was carried out with a Tecan Infinite
F200 Pro microplate reader (TECAN) at 450 nm/620 nm. Cut-off for positivity
was set at mean OD-index of normal healthy donor (NHD) sera+3 SD. Human
and murine cytokines/chemokines in sera/plasma and peritoneal lavages were
analyzed by multiplex bead technology (eBioscience) and quantified by
Cathelicidins in Lupus and Arthritis
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cytofluorometry on a Gallios machine (Beckman Coulter). Serum levels of LL-37
were measured using a commercially available kit (HyCult). Cut-off for positivity
was set at mean concentration in NHD sera+2 SD.
Real time quantitative PCR
RNA from serum from WT and CRAMP2/2 mice collected at day 0, 30, and 180
after pristane injection was purified using the Direct-zol RNA MiniPrep Kit
(Zymo Research). RNA was reverse-transcribed with a high-capacity cDNA
Reverse Transcription Kit (Applied Biosystems). RT- PCR was performed using
the qPCR Mastermix Plus for SYBR Green I (Eurogentec) on a QuantStudio6Flex
(Applied Biosystems). Data were normalized to b-Actin by the DDCt method.
PCR primers were synthesized by Invitrogen: b-actin: TGTCCACCTTCCAGCA-
GATGT (for), AGCTCAGTAACAGTCCGCCTAGATGT (rev); MX-1: GATCCG
ACTTCACTTCCAGATGG (for), CATCTCAGTGGTAGTCAACCC (rev); IP-10/
CXCL10: TCCTGCTGGGTCTGAGTGGGAC (for), CGTGGCAATGATCT
CAACACGTCG (rev); IRF-7: TGATGCCGGGGACCTCTTGCT (for),
CTGCGCTCGG TGAGAGCTGG (rev).
Complex formation
Plasmacytoid dendritic cells (pDCs) were isolated from leukocyte suspensions
enriched from human blood in leukocyte reduction chambers as described [13] or
from erylysed mouse whole blood by MACS using the according isolation kits
(Miltenyi Biotec). 36105 isolated pDCs or 2,56106 whole blood cells were then
incubated in complete DMEM medium for 24 h at 37 C˚ with 0,5 mM Type A CpG
2216 (InvivoGen), 1 mg/ml R848 (Resiquimod, InvivoGen), 10 mg/ml genomic
DNA (Novagen), 1 mg/ml total RNA isolated from human cell cultures or murine
splenocytes using Trizol solution (Sigma-Aldrich), 50 mg/ml CRAMP/LL37 (both
from Innovagen), or CRAMP/LL-37 complexed to DNA or RNA, respectively, as
described [1, 4]. Type I IFN in supernatants was measured by a luciferase assay
using HEK293 IFN reporter cells as described [14] or by multiplex bead
technology (eBioscience).
Histological and histomorphometrical analysis
Paws from nai¨ve mice and mice 37 days after the first immunization were fixed
overnight in 4% formalin, decalcified with EDTA, and embedded in paraffin.
Paraffin sections were stained with haematoxylin&eosin (H&E), toluidine blue,
and tartrate-resistant acid phosphatase (TRAP) for assessment of inflammation,
proteoglycan loss in cartilage, and osteoclasts, respectively. Analysis was
performed on a Nikon microscope equipped with a digital analysis system
(OsteoMeasure). The areas of inflammation and bone erosions in all digital,
carpal and tarsal joints were evaluated in H&E- and TRAP-stained sections as the
sum of the areas of inflammation and erosions, respectively. For determination of
Cathelicidins in Lupus and Arthritis
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cartilage proteoglycan loss the areas of total cartilage and destained cartilage were
measured in sections stained with toluidine blue.
Analysis of NETosis
IgG was purified from nai¨ve mice and mice 180 days after i.p, injection of pristane
using Dynabeads Protein G (Life technologies). Concentrations were measured at
a NanoDrop machine (Thermo Fisher). Pooled heparinized whole blood from 5
mice was incubated for 3 h at 37 C˚/5% CO2 with either PBS, 100 nM PMA, 1 mg/
ml or 0.1 mg/ml polyclonal anti-mouse CRAMP (Innovagen), or 30 mg/ml
purified IgG. Erythrocytes were lysed, cells were fixed in 1xPBS/1% PFA, and
cytospins were prepared. NET-formation was analyzed by immunofluorescence
staining of nuclear and extranuclear DNA with 1 mg/ml DAPI (Invitrogen) and
with a 1:200 dilution of a rabbit anti-neutrophil elastase (NE) antibody (Abcam)
and 3.75 mg/ml FITC-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch). Cytospins were examined on a Nikon Eclipse TS 100
microscope. Quantitative morphometrical analysis of NETosis and aggregation of
cells was performed on photos of cytospins using Adobe Photoshop CS5 Extended
software. To this end, total DAPI-positive events were counted in 3 photos of each
treatment condition, and percentages of cells in aggregates .5x mean nuclear size
were calculated. Furthermore, NETs (extracellular diffuse DNA colocalizing with
neutrophil elastase) were counted and percentages of cells having undergone
NETosis were computed.
Statistical analyses
Within each set of experiments shown in one figure multiple comparisons of
groups with a control were adjusted using Dunnet’s or Bonferroni’s post-hoc test.
In the case of pairwise comparisons selected a priori the method of Bonferroni and
Holm was used for adjustment. Adjusted p-values,0.05 were considered to be
statistically significant. Levels of significance are labelled throughout the figures as
follows: *p,0.05, **p,0.01, ***p,0.001. Computations and charts were
performed using GraphPad Prism 5 software.
Results
Autoantibodies to LL-37 and raised serum levels of LL-37 but no
correlation with disease parameters in SLE
We investigated the presence of autoAbs to LL-37 in patient cohorts of SLE and
RA originating from Erlangen and Linko¨ping, respectively (S1 Table). We
detected significantly higher levels of IgG autoAbs to LL-37 in SLE sera compared
to healthy controls (p,0.001) (sensitivity 18,62%, specificity 97,01%), but not in
RA (Fig. 1A). Specificity of the anti-LL-37 antibodies was confirmed by inhibition
of the reactivity when sera were preincubated with LL-37 (Fig. 1B). Together with
anti-LL-37 autoAbs, also serum levels of LL-37 peptide were raised in 13,91% of
Cathelicidins in Lupus and Arthritis
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patients with SLE and in 11,63% of patients with RA but not in sera from healthy
donors (Fig. 1C). However, in contrast to previous reports [3], the levels of
autoAbs to LL-37 in sera of the two cohorts tested did not correlate to either
clinical or laboratory disease parameters of SLE, such as SLEDAI, anti-dsDNA
autoAbs, CRP, IFNa (Fig. 1D), or organ involvement (data not shown).
Moreover, no correlation was shown in individuals with SLE over the course of
the disease between anti-LL-37 and change in SLEDAI (Fig. 2). In line with that,
there was no significant correlation of serum levels of LL-37 peptide and disease
activity (Fig. 1E), organ involvement, or treatment (not shown). Serum levels of
LL-37 peptide did also not correlate with anti-LL-37 autoAbs (not shown).
Fig. 1. Autoantibodies against LL-37 in SLE are not linked to disease activity. (A) In patients with SLE
(n5185) but not with RA (n592) or normal healthy donors (NHD, n574) serum autoAbs to LL-37 are detected.
Shown are optical density (OD) indices, which are the ratios of the OD in the individual donor to the mean OD
in NHD sera. One dot represents one patient, horizontal bars show the means. ***P,0.001, as determined by
Kruskal-Wallis test with Dunn’s post-hoc test. Dashed line shows cutoff OD (1,93). (B) Sera of SLE patients
(n521) were preincubated with saturating concentrations of LL-37 peptide before reactivity to plate-bound LL-
37 was determined by ELISA. IgG reactivity to LL-37 can be blocked by preincubation with LL-37 peptide.
***P,0.001, as determined by Mann-Whitney U test. (C) Serum levels of LL-37 peptide are raised in a
subgroup of SLE and RA patients. One dot represents one donor. Dashed line shows cutoff OD (2,77 ng/ml).
(D) No correlation is found between SLE anti-LL-37 autoAbs and disease parameters of SLE. X-Y scatter
plots of correlations between OD indices of anti-LL-37 autoAbs in SLE patients and SLEDAI (n5163), anti-
dsDNA autoAbs (n573), or serum levels of C-reactive protein (CRP, n574) or of IFNa (n528), respectively.
Spearman coefficients (r) are depicted within the graphs. N.s., not significant. (E) Serum levels of LL-37
peptide are not linked to SLE disease activity. X-Y scatter plot of correlation between serum LL-37 levels and
SLEDAI in 110 patients with SLE. Spearman coefficient (r) is depicted within the graph. N.s., not significant.
doi:10.1371/journal.pone.0115474.g001
Cathelicidins in Lupus and Arthritis
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No differences in pristane-induced lupus in WT and CRAMP2/2
mice
To investigate the functional involvement of cathelicidins in lupus we injected
pristane intraperitoneally into C57BL/6 WT and CRAMP2/2 mice and monitored
development of autoAbs and organ involvement of PIL over 6 months. The
number of CRAMP+ cells in the peritoneum was strongly raised after pristane-
injection (Fig. 3). Pristane-injected animals developed typical lupus autoAbs such
as anti-dsDNA, anti-Sm/RNP, and anti-histone, but no differences could be
observed between CRAMP2/2 and CRAMP+/+ animals (Fig. 4). CRAMP+/+ but
not CRAMP2/2 mice also developed anti-CRAMP autoAbs. Concentrations of
Fig. 2. Longitudinal follow up of SLE patients does not uncover an association of anti-LL-37 autoAbs
and disease activity. Development over time of SLEDAI (dashed black line) and OD index of anti-LL-37
autoantibodies (red line) in 6 representative patients with SLE. A connection between anti-LL-37 and SLEDAI
is not apparent.
doi:10.1371/journal.pone.0115474.g002
Cathelicidins in Lupus and Arthritis
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inflammatory mediators were mostly increased in blood and peritoneal lavages
after pristane-priming (Fig. 5A and 5B). Again we could not detect significant
differences between CRAMP+/+ and CRAMP2/2 mice. Concentrations of IFNa
were below detection limits in both serum and peritoneal lavages (data not
shown). Expression of ISGs was mostly raised early after pristane-injection, but
there were no significant differences between CRAMP+/+ and CRAMP2/2 mice
(Fig. 5C).
As previously reported for mice on the C57BL/6 background [15, 16], we
observed only mild renal disease (deposition of complement factor C3 and IgG in
the glomeruli with mild mesangial matrix expansion, mild proteinuria, Fig. 6A–
D) after i.p. pristane-priming, but found transient hemorrhagic alveolitis
(Fig. 7A–C) that, however, only resulted in low mortality (Fig. 7D) in both
strains.
No difference in collagen-induced arthritis in CRAMP+/+ and
CRAMP2/2 mice
Cathelicidins are overexpressed during the course of arthritis and targeted by
autoAbs and have therefore been implicated in the development of arthritis in
humans and rodents [8]. However, so far any evidence about a direct contribution
to pathogenesis is missing. To assess the functional involvement of cathelicidins in
arthritis, we conducted collagen-induced arthritis (CIA) in C57BL/6 WT and
CRAMP-deficient mice. Incidence and severity as well as time of onset of CIA
were similar in WT and CRAMP2/2 mice (Fig. 8A–C). Histomorphometry
revealed no differences between CRAMP+/+ and CRAMP2/2 mice regarding
inflammation area, cartilage degradation, or bone erosions (Fig. 8D–E).
Fig. 3. Percentage of CRAMP-expressing cells is higher in pristane-injected animals. Percentage of
CRAMP+ cells in peritoneal lavage and peripheral blood of naı¨ve mice and mice 7 days after pristane-
injection. N55. *P,0.001, as determined by Student’s t-test.
doi:10.1371/journal.pone.0115474.g003
Cathelicidins in Lupus and Arthritis
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Functional implications of CRAMP for lupus pathogenesis
The effect LL-37 can have on SLE pathogenesis has been attributed to two modes
of action: firstly, LL-37 has been shown to form ionic complexes with nucleic
acids that efficiently enter plasmacytoid dendritic cells (pDCs) or monocytes and
are retained in early endosomes where they trigger sustained stimulation of TLRs
[1, 4]. Secondly, anti-LL37 antibodies were reported to induce formation of
neutrophil extracellular traps (NETs). As a consequence of this, the abundant
DNA that is present in NETs bound to LL-37 stimulates pDCs to produce Type I
IFN [3].
To determine if similar pathways occur in the murine system, we incubated
pDCs isolated from human and mouse blood by MACS with free DNA/RNA or
RNA/DNA complexed to CRAMP (Fig. 9). We detected a significant, albeit low
induction of IFNa by RNA complexed to both LL-37 and CRAMP, respectively.
Fig. 4. Development of lupus autoAbs in C57BL/6 WT and CRAMP2/2 mice. CRAMP2/2 and CRAMP+/+
mice develop similar levels of lupus autoantibodies after pristane-injection. Autoantibodies to dsDNA, Sm/
RNP, histone, and CRAMP were analysed in sera of naı¨ve and pristane-primed mice (n511–15) by ELISA
and compared by ANOVA with Bonferroni post-hoc test. Red horizontal bars show means. No significant
differences could be found except for autoantibodies to CRAMP. *P,0.05, ***P,0.001.
doi:10.1371/journal.pone.0115474.g004
Cathelicidins in Lupus and Arthritis
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Complexes with DNA induced a significant induction of IFNa production only in
human cells. Considering that in PIL, monocytes have been described as the main
producers of IFNa [17] we also used whole blood from WT and CRAMP-deficient
mice for our stimulation experiments. However, IFNa production was not
significantly enhanced by stimulation with DNA-CRAMP-complexes (data not
shown). Thus, in our hands CRAMP shows similar capacity as LL-37 to stimulate
IFNa production via complexation to RNA. However, the effect is much lower
than previously described [1] and complexation with DNA does not significantly
induce IFNa production in mouse cells.
To address the second described mechanism, we incubated mouse blood from
nai¨ve WT mice with IgG isolated from serum of healthy mice and mice with PIL
(Fig. 10). After erythrocyte lysis, we prepared cytospins and stained them with a
DNA-dye (DAPI) and an antibody to neutrophil elastase (NE). As a control we
also used blood cells stimulated with a polyclonal anti-CRAMP antibody, with
PMA, a well-known inducer of NETosis, and unstimulated blood cells. Neither
incubation with IgG isolated from serum nor with purified anti-CRAMP antibody
induced NETosis, identifiable from diffuse extracellular DNA colocalizing with
NE [18, 19]. However, IgG from mice with PIL induced agglomeration of blood
Fig. 5. Cytokine/chemokine levels and expression of ISGs in sera and peritoneal lavages of naı¨ve and pristane-injected mice are not significantly
influenced by CRAMP-deficiency. Scatter plots show individual measurements and means from naı¨ve and pristane-injected mice of cytokine/chemokine
concentrations in serum (A) or peritoneal lavage (B), or of expression of Interferon I-stimulated genes in serum (C), normalized to b-actin expression. One
dot represents one mouse. No significant differences were found by ANOVA with Bonferroni post-hoc test.
doi:10.1371/journal.pone.0115474.g005
Cathelicidins in Lupus and Arthritis
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cells (Fig. 10C & 10D). These agglomerates were induced regardless if the IgG was
obtained from anti-CRAMP-positive or -negative PIL serum but not by IgG
derived from healthy mice. Also purified anti-CRAMP antibody induced similar
aggregates (Fig. 10E). Importantly, these aggregates could be distinguished from
NETs because agglomerated cells retained a nuclear localization of DNA and a
strictly cytoplasmic expression of NE (Fig. 10G).
Discussion
Cathelicidins are cationic peptides that are synthesized and stored as inactive
precursors in neutrophil granules and are proteolytically maturated before they
Fig. 6. Mild renal disease develops after pristane-injection in both WT andCRAMP2/2 mice.
Representative immunofluorescence images showing predominantly mesangial IgG-deposits (A) and
complement C3 deposits (B) in WT and CRAMP-deficient mice before and 6 months after pristane-injection.
Scale bars, 50 mm (C) Representative PAS-stainings of kidneys from unchallenged and pristane-injected WT
and CRAMP2/2 mice showing mild mesangial cell and matrix expansion at day 180 in both groups. Scale
bars, 50 mm (D) Quantification of proteinuria in CRAMP+/+ and CRAMP2/2 mice before and 180 days after
pristane-injection.
doi:10.1371/journal.pone.0115474.g006
Cathelicidins in Lupus and Arthritis
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are released as active AMPs [20, 21]. In humans there is only one cathelicidin gene
(CAMP) encoding the precursor protein hCAP18 which yields the 37 amino acid
long mature peptide LL-37. After being released LL-37 adopts a-helical
conformation when interacting with lipid bilayers and anionic compounds
[22, 23]. Mice also have only one cathelicidin precursor, which is processed to
produce the mature 39-residue a-helical peptide CRAMP [24].
Cathelicidins are an important group of polypeptides released by activated
neutrophil granulocytes in inflamed tissues. Neutrophils, long thought to be
merely terminally differentiated programmed executor cells, have recently been
identified as active participants in triggering and resolving inflammation
(reviewed in [25, 26], and [27]). Especially, their ability to release NETs has been
in the focus of many interesting studies. In lupus and arthritis, the DNA and
Fig. 7. Transient alveolar haemorrhage develops after pristane-injection in both WT and CRAMP2/2
mice. (A) Classification of lung pathology in pristane-injected mice. Representative images and H&E-
stainings of C57BL/6 mice two weeks after pristane-injection, with lungs showing no hemorrhage, partial, or
full hemorrhage. Scale bars, 200 mm. (B) Time course of pristane-induced alveolar hemorrhage in WT and
CRAMP2/2 mice. Incidence and types of gross pathology at day 0, day 14, and day 180 after pristane-
injection. (C) Low mortality after pristane-injection in both CRAMP+/+ (n514) and CRAMP2/2 (n515) mice. No
significant differences could be found by Logrank test.
doi:10.1371/journal.pone.0115474.g007
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Fig. 8. Comparison of collagen-induced arthritis (CIA) in WT and CRAMP-deficient mice. Incidence (A)
of CIA and severity in affected mice (B). No significant differences could be found by comparing area under
the curves of arthritic WT mice (n59) and CRAMP-deficient mice (n59) by Student’s t-test. Curves show
means ¡ S.E.M. (C) Onset of CIA is not significantly different in CRAMP+/+ and CRAMP2/2 mice. (D)
Histomorphometric analysis of hind paws from WT and CRAMP2/2 mice for synovial inflammation, cartilage
damage, and bone erosion. Shown are scatter plots of individual measurements and means. One dot
represents one mouse. No significant differences could be found by Student’s t-test. (E) Representative H&E
stainings of joint sections from naı¨ve mice and mice 37 days after collagen-injection. Left panels show
Cathelicidins in Lupus and Arthritis
PLOS ONE | DOI:10.1371/journal.pone.0115474 December 23, 2014 14 / 19
attached proteins (such as AMPs) have been suggested to serve as source for the
development of autoreactivity [2, 3, 8].
In this study, we investigated autoreactivity to cathelicidins and their direct
contribution to lupus and arthritis pathogenesis. Although we found autoAbs in
lupus against cathelicidins, we could not detect a functional correlation to disease
activity such as SLEDAI and other disease parameters. Furthermore, experimental
lupus was not inhibited in the absence of cathelicidins, although CRAMP2/2 mice
were able to form NETs (not shown).
For our studies, we used the PIL mouse model that is induced by i.p. injection
of the isoprenoid alkane pristane and is mainly driven by TLR7-mediated
production of type I IFN by inflammatory monocytes [28]. The exact mechanism
of action of pristane has yet not been fully elucidated, but it is known that it
induces massive cell death [29, 30]. In WT mice, RNA released from dying cells
can then bind to CRAMP locally released from infiltrating neutrophils or other
cell types. These complexes have been shown to gain access to pDCs and to
monocytes [1, 4, 31] in humans and trigger prolonged type I IFN production. In
contrast, in SLE cathelicidins were suggested to contribute to pathogenesis by
shuttling DNA into pDCs and triggering prolonged stimulation of TLR9.
Therefore, although we do not claim that PIL represents all aspects of SLE in
humans, we consider it a useful model for addressing the importance of
cathelicidins for lupus pathogenesis. However, we cannot exclude a role of
cathelicidins in genetical lupus models such as NZB/W F1 or MRL/lpr mice.
sections from WT mice, right panels sections from CRAMP-deficient mice. Arrows indicate areas where
inflammatory synovial tissue invades the subchondral space. Scale bars, 500 mm.
doi:10.1371/journal.pone.0115474.g008
Fig. 9. Complexes of cathelicidins and RNA or DNA induce low production of IFNa. Bars show means
and SEM of IFNa concentrations in supernatants from isolated human (A) or mouse (B) pDCs after incubation
with free genomic DNA, free self-RNA, or DNA/RNA complexed to LL-37 (A) or (CRAMP). IFNa production
from unstimulated pDCs or pDCs incubated with LL-37/CRAMP only was determined as a negative control,
CpG2216 and R848 (Resiquimod) were used as a positive control for stimulation of TLR9 and TLR7/8,
respectively. *p,0.05, as determined by Student’s t-test. N54–7.
doi:10.1371/journal.pone.0115474.g009
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From our results we deduct that autoreactivity against cathelicidins does not
seem to be indispensable for lupus and arthritis pathogenesis. However, in
humans other cationic AMPs such as the b-defensins hBD2 and 3 and lysozyme
have recently been shown to possess strong binding capacity of nucleic acid and
stimulate pDC-activation and inflammation in a way similar to cathelicidins
[32, 33]. Thus, whether autoreactivity against exposed cathelicidins is an
epiphenomenon due to extensive disease-induced overexpression, or if these
AMPs could potentially compensate for the absence of cathelicidins is a question
that merits further studies.
Fig. 10. Lupus antibodies induce agglomeration of mouse blood cells but no NETosis. Representative
fluorescence microscopy images and morphometry of murine blood cells incubated with various stimuli/
controls and stained for DNA (DAPI, red) and neutrophil elastase (green). Incubation with PBS (A), IgG
purified from naı¨ve WT mice (B), IgG purified from PIL anti-CRAMP positive sera from WT mice (C), IgG
purified from PIL anti-CRAMP-negative sera from CRAMP2/2 mice (D), purified anti-CRAMP antibody (E), or
PMA (F). The picture in (G) shows only NE-staining and reveals strictly cytoplasmatic expression of NE.
Control stainings were performed using secondary FITC-conjugated Ab only (H). Scale bars, 100 mm. Neither
incubation with IgG isolated from serum nor incubation with purified anti-CRAMP antibody induced NETosis,
identifiable from extracellular washy DNA colocalizing with NE (as shown in F, white arrows). However, IgG
from mice with PIL induced agglomeration of blood cells. (I) Quantification of the percentage of cells in
aggregates .5x mean nuclear size and of cells having undergone NETosis. Bars show the mean and SD of 3
pictures for each treatment condition.
doi:10.1371/journal.pone.0115474.g010
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